As prostate cancer expands to reach the bones, it often becomes fatal. The process at the back of this fatal element might possibly be used against this cancer type as an objective in bone-targeting radiation and possible novel therapies. In a new study, researchers from the Duke Cancer Institute described how prostate cancer cells develop their ability to imitate bone-forming cells named osteoblasts. This quality enables the cancer-causing cells to grow in the bone microenvironment. Read more.
